- Home
- GCTK vs GLMD Comparison
GCTK vs GLMD Comparison
Compare GCTK & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GCTK | GLMD |
|---|---|---|
| Founded | 2001 | 2000 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.6M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | GCTK | GLMD |
|---|---|---|
| Price | $5.84 | $1.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.9K | ★ 6.3M |
| Earning Date | 11-13-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.22 | $0.74 |
| 52 Week High | $468.00 | $3.61 |
Technical Indicators
Market Signals| Indicator | GCTK | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 46.71 |
| Support Level | $5.53 | $1.02 |
| Resistance Level | $6.71 | $0.99 |
| Average True Range (ATR) | 0.46 | 0.08 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 45.83 | 60.50 |
Price Performance
Historical ComparisonAbout GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.